These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8641910)

  • 1. Effect of recombinant human granulocyte colony stimulating factor (R-metHuG-CSF) as an adjunct to large-field radiotherapy: a phase I study.
    Kolotas C; Zamboglou N; Schnabel T; Bojar H; Wintzer A; Vogt HG; Schmitt G
    Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):137-42. PubMed ID: 8641910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of granulocyte colony stimulating factor in radiotherapy induced neutropenia: clinical and laboratory studies.
    Mac Manus MP; McCormick D; Trimble A; Abram WP
    Eur J Cancer; 1995; 31A(3):302-7. PubMed ID: 7540401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of filgrastim (G-CSF) in Hodgkin's disease patients treated with radiation therapy.
    Knox SJ; Fowler S; Marquez C; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):445-50. PubMed ID: 7506247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.
    de Wit R; Verweij J; Bontenbal M; Kruit WH; Seynaeve C; Schmitz PI; Stoter G
    J Natl Cancer Inst; 1996 Oct; 88(19):1393-8. PubMed ID: 8827017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation.
    Cioch M; Jawniak D; Kotwica K; Wach M; Mańko J; Gorący A; Klimek P; Mazurkiewicz E; Jarosz P; Hus M
    Transplant Proc; 2014 Oct; 46(8):2882-4. PubMed ID: 25380941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias.
    Bonilla MA; Dale D; Zeidler C; Last L; Reiter A; Ruggeiro M; Davis M; Koci B; Hammond W; Gillio A; Welte K
    Br J Haematol; 1994 Dec; 88(4):723-30. PubMed ID: 7529539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia.
    Boxer LA; Hutchinson R; Emerson S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S39-46. PubMed ID: 1370264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of therapeutic schedules for administering granulocyte colony-stimulating factor to nonhuman primates after high-dose chemotherapy.
    Meisenberg BR; Davis TA; Melaragno AJ; Stead R; Monroy RL
    Blood; 1992 May; 79(9):2267-72. PubMed ID: 1373969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
    Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
    Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
    Singh AD; Parmar S; Patel K; Shah S; Shore T; Gergis U; Mayer S; Phillips A; Hsu JM; Niesvizky R; Mark TM; Pearse R; Rossi A; van Besien K
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):288-293. PubMed ID: 29061534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.
    Ganser A; Seipelt G; Verbeek W; Ottmann OG; Maurer A; Kolbe K; Hess U; Elsner S; Reutzel R; Wörmann B
    Leukemia; 1994 Mar; 8(3):369-75. PubMed ID: 7510354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
    Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
    Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
    Schmitz N; Dreger P; Zander AR; Ehninger G; Wandt H; Fauser AA; Kolb HJ; Zumsprekel A; Martin A; Hecht T
    Bone Marrow Transplant; 1995 Feb; 15(2):261-6. PubMed ID: 7539668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two strategies for the treatment of radiogenic leukopenia using granulocyte colony stimulating factor.
    Adamietz IA; Rosskopf B; Dapper FD; von Lieven H; Boettcher HD
    Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):61-7. PubMed ID: 8641928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.
    Tjan-Heijnen VC; Biesma B; Festen J; Splinter TA; Cox A; Wagener DJ; Postmus PE
    J Clin Oncol; 1998 Aug; 16(8):2708-14. PubMed ID: 9704721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of recombinant human granulocyte colony-stimulating factor on efficacy of radiation therapy in tumor-bearing rats.
    Kabaya K; Watanabe M; Kusaka M; Akahori H; Seki M; Fushiki M
    Radiat Res; 1994 Jul; 139(1):92-6. PubMed ID: 7517051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.